PODD Insulet Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
13:12
May 06
TheLAPurchaser L/S Equity trader
The author mocks the T2 diabetes thesis for PODD, implying the stock is failing and calling it dead tech.
PODD
HIGH
13:11
May 06
TheLAPurchaser L/S Equity trader
The author mocks the T2 diabetes thesis for PODD, implying it is failing and questioning those who believed in it.
PODD
HIGH
23:55
Apr 23
Jim Cramer Host, Mad Money CNBC
Insulet too expensive due to GLP-1.
Insulet is the most declined stock in healthcare and remains too expensive because the GLP-1 drug threat is existential.
PODD 1ST
MED

About PODD Analyst Coverage

Buzzberg tracks PODD (Insulet) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 3 total trade ideas tracked.